These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31154631)

  • 1. Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Yuan J; Xu GM; Ding J
    Adv Ther; 2019 Aug; 36(8):2062-2071. PubMed ID: 31154631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Paciaroni M; Ince B; Hu B; Jeng JS; Kutluk K; Liu L; Lou M; Parfenov V; Wong KSL; Zamani B; Paek D; Min Han J; Del Aguila M; Girotra S
    Cardiovasc Ther; 2019; 2019():1607181. PubMed ID: 31867054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
    Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
    BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Koo BK; Kang J; Park KW; Rhee TM; Yang HM; Won KB; Rha SW; Bae JW; Lee NH; Hur SH; Yoon J; Park TH; Kim BS; Lim SW; Cho YH; Jeon DW; Kim SH; Han JK; Shin ES; Kim HS;
    Lancet; 2021 Jun; 397(10293):2487-2496. PubMed ID: 34010616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with a P2Y
    Chiarito M; Sanz-Sánchez J; Cannata F; Cao D; Sturla M; Panico C; Godino C; Regazzoli D; Reimers B; De Caterina R; Condorelli G; Ferrante G; Stefanini GG
    Lancet; 2020 May; 395(10235):1487-1495. PubMed ID: 32386592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor or Clopidogrel as Antiplatelet Agents in Patients with Chronic Kidney Disease and Cardiovascular Disease: A Meta-analysis.
    Guo Y; Ge P; Li Z; Xiao J; Xie L
    Am J Cardiovasc Drugs; 2023 Sep; 23(5):533-546. PubMed ID: 37530990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.
    Bundhun PK; Huang F
    BMC Cardiovasc Disord; 2018 May; 18(1):78. PubMed ID: 29720092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
    Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
    JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
    Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
    Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
    J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis.
    Yang Y; Huang Z; Zhang X
    Medicine (Baltimore); 2021 Dec; 100(50):e27804. PubMed ID: 34918630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis.
    Elmariah S; Doros G; Benavente OR; Bhatt DL; Connolly SJ; Yusuf S; Steinhubl SR; Liu Y; Hsieh WH; Yeh RW; Mauri L
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005795. PubMed ID: 29311290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
    N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin plus clopidogrel
    Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
    Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis.
    Tasoudis PT; Kyriakoulis IG; Sagris D; Diener HC; Ntaios G
    Thromb Haemost; 2022 Nov; 122(11):1879-1887. PubMed ID: 35577054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
    J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.